If you have advanced Parkinson’s disease (PD), you may hear about a treatment option called vyalev (foscarbidopa/foslevodopa). It was approved by the FDA in 2024 ...
Treatment with Crexont statistically significantly improved “On” time without troublesome dyskinesia compared with carbidopa/levodopa IR. The Food and Drug Administration (FDA) has approved Crexont ® ...
When you take medication by mouth, you feel its effects for as long as it’s circulating in your bloodstream and reaching its therapeutic target. Once drug levels in your bloodstream diminish, symptoms ...
One effective strategy for using Parkinson’s drugs is to start with a dopamine agonist. Explain to patients that this is the background dosing they will take on a regular schedule. Begin with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results